跳至主要内容
临床试验/NCT00877526
NCT00877526已完成不适用

DiabCare Asia 2008 (Malaysia): A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Diabetic Patients in Asia & To Evaluate Perceptions and Practices of Physicians & Patients About Diabetes Management in Asia

Novo Nordisk A/S1 个研究点 分布在 1 个国家目标入组 1,670 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,670
试验地点
1
主要终点
Mean age of onset of type 1 and type 2 diabetes mellitus, respectively

研究概览

简要总结

This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, and complications in diabetic subjects in Asia.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Diabetic patients registered in the particular centre for more than 12 months.
  • Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit.
  • Patients willing to sign informed consent form.

排除标准

  • Repetition of any patient as patients should not be included twice for any reason.
  • Unwilling to participate or unable to comply with protocol requirements.

结局指标

主要结局

Mean age of onset of type 1 and type 2 diabetes mellitus, respectively

时间窗: at baseline visit/study start

Mean duration of treatment of type 2 Diabetes mellitus

时间窗: at baseline visit/study start

Percentage of patients on insulin and Oral Anti-Diabetics Drugs (OADs) theraphy, respectively

时间窗: at baseline visit/study start

Mean duration of diabetes in type 1 and type 2 diabetic patients respectively

时间窗: at baseline visit/study start

Mean FPG (Fasting plasma glucose), PPG (Post prandial glucose) and HbA1c of diabetic patients

时间窗: at baseline visit/study start

Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively

时间窗: at baseline visit/study start

Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively

时间窗: at baseline visit/study start

次要结局

  • Patients' perception will be analysed through patient questionnaire measuring: Psychological well-being, Quality of Life and patients' compliant to treatmen(at baseline visit/study start)
  • Duration of diabetes associated with highest number of diabetic complications(at baseline visit/study start)
  • Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy)(at baseline visit/study start)
  • Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control(at baseline visit/study start)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验